Nomogram for Prediction of Prostate Cancer with Serum Prostate Specific Antigen Less than 10 ng/mL
Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is reported that PSA is associated with a high false-positive rate and prostate biopsy also has various procedure-related complications. Therefor...
Saved in:
Published in | Journal of Korean medical science Vol. 29; no. 3; pp. 338 - 342 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Academy of Medical Sciences
01.03.2014
대한의학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1011-8934 1598-6357 1598-6357 |
DOI | 10.3346/jkms.2014.29.3.338 |
Cover
Abstract | Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is reported that PSA is associated with a high false-positive rate and prostate biopsy also has various procedure-related complications. Therefore, the authors have devised a nomogram, which can be used to estimate the risk of PCA, using available clinical data for men with a serum PSA less than 10 ng/mL. Prostate biopsies were obtained from 2,139 patients from January 1998 to March 2011. Of them, 1,171 patients with a serum PSA less than 10 ng/mL were only included in this study. Patient age, PSA, free PSA, prostate volume, PSA density and percent free PSA ratio were analyzed. Among 1,171 patients, 255 patients (21.8%) were diagnosed as PCA. Multivariate analyses showed that patient age, prostate volume, PSA and percent free PSA had statistically significant relationships with PCA (P < 0.05) and were used as nomogram predictor variables. The area under the (ROC) curve for all factors in a model predicting PCA was 0.759 (95% CI, 0.716-0.803). |
---|---|
AbstractList | Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is reported that PSA is associated with a high false-positive rate and prostate biopsy also has various procedure-related complications. Therefore, the authors have devised a nomogram, which can be used to estimate the risk of PCA, using available clinical data for men with a serum PSA less than 10 ng/mL. Prostate biopsies were obtained from 2,139 patients from January 1998 to March 2011. Of them, 1,171 patients with a serum PSA less than 10 ng/mL were only included in this study. Patient age, PSA, free PSA, prostate volume, PSA density and percent free PSA ratio were analyzed. Among 1,171 patients, 255 patients (21.8%) were diagnosed as PCA. Multivariate analyses showed that patient age, prostate volume, PSA and percent free PSA had statistically significant relationships with PCA (P < 0.05) and were used as nomogram predictor variables. The area under the (ROC) curve for all factors in a model predicting PCA was 0.759 (95% CI, 0.716-0.803). Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is reported that PSA is associated with a high false-positive rate and prostate biopsy also has various procedure-related complications. Therefore, the authors have devised a nomogram, which can be used to estimate the risk of PCA, using available clinical data for men with a serum PSA less than 10 ng/mL. Prostate biopsies were obtained from 2,139 patients from January 1998 to March 2011. Of them, 1,171 patients with a serum PSA less than 10 ng/mL were only included in this study. Patient age, PSA, free PSA, prostate volume, PSA density and percent free PSA ratio were analyzed. Among 1,171 patients, 255 patients (21.8%) were diagnosed as PCA. Multivariate analyses showed that patient age, prostate volume, PSA and percent free PSA had statistically significant relationships with PCA (P < 0.05) and were used as nomogram predictor variables. The area under the (ROC) curve for all factors in a model predicting PCA was 0.759 (95% CI, 0.716-0.803).Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is reported that PSA is associated with a high false-positive rate and prostate biopsy also has various procedure-related complications. Therefore, the authors have devised a nomogram, which can be used to estimate the risk of PCA, using available clinical data for men with a serum PSA less than 10 ng/mL. Prostate biopsies were obtained from 2,139 patients from January 1998 to March 2011. Of them, 1,171 patients with a serum PSA less than 10 ng/mL were only included in this study. Patient age, PSA, free PSA, prostate volume, PSA density and percent free PSA ratio were analyzed. Among 1,171 patients, 255 patients (21.8%) were diagnosed as PCA. Multivariate analyses showed that patient age, prostate volume, PSA and percent free PSA had statistically significant relationships with PCA (P < 0.05) and were used as nomogram predictor variables. The area under the (ROC) curve for all factors in a model predicting PCA was 0.759 (95% CI, 0.716-0.803). Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy isstill necessary to confirm prostate cancer (PCA). However, it is reported that PSA isassociated with a high false-positive rate and prostate biopsy also has various procedurerelatedcomplications. Therefore, the authors have devised a nomogram, which can beused to estimate the risk of PCA, using available clinical data for men with a serum PSAless than 10 ng/mL. Prostate biopsies were obtained from 2,139 patients from January1998 to March 2011. Of them, 1,171 patients with a serum PSA less than 10 ng/mL wereonly included in this study. Patient age, PSA, free PSA, prostate volume, PSA density andpercent free PSA ratio were analyzed. Among 1,171 patients, 255 patients (21.8%) werediagnosed as PCA. Multivariate analyses showed that patient age, prostate volume, PSAand percent free PSA had statistically significant relationships with PCA (P < 0.05) andwere used as nomogram predictor variables. The area under the (ROC) curve for all factorsin a model predicting PCA was 0.759 (95% CI, 0.716-0.803). KCI Citation Count: 2 Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is reported that PSA is associated with a high false-positive rate and prostate biopsy also has various procedure-related complications. Therefore, the authors have devised a nomogram, which can be used to estimate the risk of PCA, using available clinical data for men with a serum PSA less than 10 ng/mL. Prostate biopsies were obtained from 2,139 patients from January 1998 to March 2011. Of them, 1,171 patients with a serum PSA less than 10 ng/mL were only included in this study. Patient age, PSA, free PSA, prostate volume, PSA density and percent free PSA ratio were analyzed. Among 1,171 patients, 255 patients (21.8%) were diagnosed as PCA. Multivariate analyses showed that patient age, prostate volume, PSA and percent free PSA had statistically significant relationships with PCA ( P < 0.05) and were used as nomogram predictor variables. The area under the (ROC) curve for all factors in a model predicting PCA was 0.759 (95% CI, 0.716-0.803). |
Author | Lee, Jeong Zoo Ahn, Jae Hyun Ha, Hong Koo Chung, Moon Kee |
AuthorAffiliation | Department of Urology and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea |
AuthorAffiliation_xml | – name: Department of Urology and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea |
Author_xml | – sequence: 1 givenname: Jae Hyun surname: Ahn fullname: Ahn, Jae Hyun organization: Department of Urology and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea – sequence: 2 givenname: Jeong Zoo surname: Lee fullname: Lee, Jeong Zoo organization: Department of Urology and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea – sequence: 3 givenname: Moon Kee surname: Chung fullname: Chung, Moon Kee organization: Department of Urology and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea – sequence: 4 givenname: Hong Koo orcidid: 0000-0002-8240-7765 surname: Ha fullname: Ha, Hong Koo organization: Department of Urology and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24616581$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001858339$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kU1vEzEQhi1URD_gD3BAPnLZ1B9rr31BiqIClSJAtJwtxztO3Ozawd6A-Pc4DbTAgdOMZ553ZuT3HJ3EFAGhl5TMOG_l5d12LDNGaDtjesZrTT1BZ1Ro1UguupOaE0obpXl7is5LuSOECcH4M3TKWkmlUPQMrT6kMa2zHbFPGX_K0Ac3hRRx8vWVymQnwAsbHWT8PUwbfAN5Pz62bnbggg8Oz-MU1hDxEkrB08ZGTAmO68tx-Rw99XYo8OJXvEBf3l7dLt43y4_vrhfzZeNaLqaGes-c7yVQkEJL5ywQDW0ra95pQon1qvO91h1fUQZW2lZKzS2o3llGPb9Ar49zY_Zm64JJNtzHdTLbbOafb6-N6DjpWEXfHNHdfjVC7yBO2Q5ml8No84974d-dGDZ1zDfDdSso6x537XL6uocymTEUB8NgI6R9MVQQ2SnNpKzoqz93PSz57UEF2BFw9VNLBv-AUGIORpuD0eZgtGHa8FpTVaT-EblQDanO1XvD8D_pT9Lgr5k |
CitedBy_id | crossref_primary_10_1007_s00432_017_2389_3 crossref_primary_10_1002_pros_24625 crossref_primary_10_1186_s12894_022_01116_2 crossref_primary_10_1371_journal_pone_0106933 crossref_primary_10_1097_MD_0000000000028196 crossref_primary_10_14366_usg_15065 crossref_primary_10_1016_j_ajur_2015_04_023 crossref_primary_10_1016_j_crad_2019_02_002 crossref_primary_10_3349_ymj_2016_57_3_565 crossref_primary_10_12688_f1000research_18892_1 crossref_primary_10_29220_CSAM_2021_28_4_339 crossref_primary_10_1186_s12889_021_10730_y crossref_primary_10_1016_j_diabres_2018_05_036 crossref_primary_10_29220_CSAM_2018_25_3_297 crossref_primary_10_1016_j_afju_2017_09_004 |
Cites_doi | 10.1111/j.1464-410X.1987.tb09137.x 10.1016/S0090-4295(02)02287-2 10.1056/NEJMoa031918 10.1111/j.1442-2042.2008.02058.x 10.1016/j.urology.2011.04.042 10.1016/j.eururo.2010.08.041 10.1016/S0090-4295(98)00205-2 10.1056/NEJM199104253241702 10.1016/j.juro.2009.11.043 10.1016/j.eururo.2012.06.003 10.1016/S0090-4295(97)00451-2 10.1097/01.ju.0000158039.94467.5d 10.1056/NEJMoa0810084 10.1016/S0090-4295(99)00213-7 10.1016/j.eururo.2011.12.058 10.1093/annonc/mdi098 10.1007/s10552-006-0087-6 10.1056/NEJMoa0810696 10.1016/j.juro.2011.06.057 |
ContentType | Journal Article |
Copyright | 2014 The Korean Academy of Medical Sciences. 2014 |
Copyright_xml | – notice: 2014 The Korean Academy of Medical Sciences. 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ACYCR |
DOI | 10.3346/jkms.2014.29.3.338 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1598-6357 |
EndPage | 342 |
ExternalDocumentID | oai_kci_go_kr_ARTI_573072 PMC3945127 24616581 10_3346_jkms_2014_29_3_338 |
Genre | Journal Article |
GroupedDBID | --- 29K 2WC 3O- 5-W 53G 5GY 8JR 8XY 9ZL AAYXX ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION CS3 D-I DIK DU5 E3Z EBS EF. EJD F5P FRP GROUPED_DOAJ GX1 HYE KQ8 M48 O5R O5S OK1 OVT PGMZT RNS RPM TR2 W2D XSB CGR CUY CVF ECM EIF NPM 7X8 5PM 08R ACYCR M~E |
ID | FETCH-LOGICAL-c435t-1ff2cfd6e1e6596ccae09e44696c79010af87fd9973b12ea6a46693ae8dca21f3 |
IEDL.DBID | M48 |
ISSN | 1011-8934 1598-6357 |
IngestDate | Tue Nov 21 21:35:27 EST 2023 Thu Aug 21 14:05:33 EDT 2025 Fri Jul 11 06:54:17 EDT 2025 Mon Jul 21 05:50:35 EDT 2025 Tue Jul 01 01:44:49 EDT 2025 Thu Apr 24 23:09:55 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Prostatic Neoplasms Biopsy Prostate Nomograms |
Language | English |
License | http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c435t-1ff2cfd6e1e6596ccae09e44696c79010af87fd9973b12ea6a46693ae8dca21f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-000345.2014.29.3.014 |
ORCID | 0000-0002-8240-7765 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3346/jkms.2014.29.3.338 |
PMID | 24616581 |
PQID | 1506789266 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_573072 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3945127 proquest_miscellaneous_1506789266 pubmed_primary_24616581 crossref_primary_10_3346_jkms_2014_29_3_338 crossref_citationtrail_10_3346_jkms_2014_29_3_338 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-03-01 |
PublicationDateYYYYMMDD | 2014-03-01 |
PublicationDate_xml | – month: 03 year: 2014 text: 2014-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Journal of Korean medical science |
PublicationTitleAlternate | J Korean Med Sci |
PublicationYear | 2014 |
Publisher | The Korean Academy of Medical Sciences 대한의학회 |
Publisher_xml | – name: The Korean Academy of Medical Sciences – name: 대한의학회 |
References | 10.3346/jkms.2014.29.3.338_ref3 Nam (10.3346/jkms.2014.29.3.338_ref16) 2010; 183 Andriole (10.3346/jkms.2014.29.3.338_ref4) 2009; 360 Ilic (10.3346/jkms.2014.29.3.338_ref11) 2007; 18 Carlson (10.3346/jkms.2014.29.3.338_ref18) 1998; 52 10.3346/jkms.2014.29.3.338_ref1 Boyle (10.3346/jkms.2014.29.3.338_ref2) 2005; 16 Ferro (10.3346/jkms.2014.29.3.338_ref13) 1987; 60 Catalona (10.3346/jkms.2014.29.3.338_ref5) 1991; 324 Schröder (10.3346/jkms.2014.29.3.338_ref6) 2009; 360 Gancarczyk (10.3346/jkms.2014.29.3.338_ref10) 2003; 61 Chun (10.3346/jkms.2014.29.3.338_ref8) 2010; 58 Loeb (10.3346/jkms.2014.29.3.338_ref14) 2011; 186 Kawamura (10.3346/jkms.2014.29.3.338_ref17) 2008; 15 Zaytoun (10.3346/jkms.2014.29.3.338_ref22) 2011; 78 Wang (10.3346/jkms.2014.29.3.338_ref12) 1979; 17 Wagenlehner (10.3346/jkms.2014.29.3.338_ref9) 2013; 63 Eastham (10.3346/jkms.2014.29.3.338_ref19) 1999; 54 Loeb (10.3346/jkms.2014.29.3.338_ref15) 2012; 61 Karakiewicz (10.3346/jkms.2014.29.3.338_ref20) 2005; 173 Optenberg (10.3346/jkms.2014.29.3.338_ref21) 1997; 50 Thompson (10.3346/jkms.2014.29.3.338_ref7) 2004; 350 15163773 - N Engl J Med. 2004 May 27;350(22):2239-46 89106 - Invest Urol. 1979 Sep;17(2):159-63 1707140 - N Engl J Med. 1991 Apr 25;324(17):1156-61 10510933 - Urology. 1999 Oct;54(4):709-13 9372872 - Urology. 1997 Nov;50(5):665-72 19297565 - N Engl J Med. 2009 Mar 26;360(13):1310-9 9730460 - Urology. 1998 Sep;52(3):455-61 22244150 - Eur Urol. 2012 Jun;61(6):1110-4 12639653 - Urology. 2003 Mar;61(3):589-95 22704727 - Eur Urol. 2013 Mar;63(3):521-7 18462353 - Int J Urol. 2008 Jul;15(7):598-603 20089283 - J Urol. 2010 Mar;183(3):963-8 2441790 - Br J Urol. 1987 Jul;60(1):69-73 20884114 - Eur Urol. 2010 Dec;58(6):851-64 21705045 - Urology. 2011 Aug;78(2):392-8 15879784 - J Urol. 2005 Jun;173(6):1930-4 21944136 - J Urol. 2011 Nov;186(5):1830-4 15718248 - Ann Oncol. 2005 Mar;16(3):481-8 17206534 - Cancer Causes Control. 2007 Apr;18(3):279-85 19297566 - N Engl J Med. 2009 Mar 26;360(13):1320-8 |
References_xml | – ident: 10.3346/jkms.2014.29.3.338_ref1 – volume: 60 start-page: 69 year: 1987 ident: 10.3346/jkms.2014.29.3.338_ref13 publication-title: Br J Urol doi: 10.1111/j.1464-410X.1987.tb09137.x – ident: 10.3346/jkms.2014.29.3.338_ref3 – volume: 61 start-page: 589 year: 2003 ident: 10.3346/jkms.2014.29.3.338_ref10 publication-title: Urology doi: 10.1016/S0090-4295(02)02287-2 – volume: 350 start-page: 2239 year: 2004 ident: 10.3346/jkms.2014.29.3.338_ref7 publication-title: N Engl J Med doi: 10.1056/NEJMoa031918 – volume: 15 start-page: 598 year: 2008 ident: 10.3346/jkms.2014.29.3.338_ref17 publication-title: Int J Urol doi: 10.1111/j.1442-2042.2008.02058.x – volume: 78 start-page: 392 year: 2011 ident: 10.3346/jkms.2014.29.3.338_ref22 publication-title: Urology doi: 10.1016/j.urology.2011.04.042 – volume: 58 start-page: 851 year: 2010 ident: 10.3346/jkms.2014.29.3.338_ref8 publication-title: Eur Urol doi: 10.1016/j.eururo.2010.08.041 – volume: 52 start-page: 455 year: 1998 ident: 10.3346/jkms.2014.29.3.338_ref18 publication-title: Urology doi: 10.1016/S0090-4295(98)00205-2 – volume: 324 start-page: 1156 year: 1991 ident: 10.3346/jkms.2014.29.3.338_ref5 publication-title: N Engl J Med doi: 10.1056/NEJM199104253241702 – volume: 183 start-page: 963 year: 2010 ident: 10.3346/jkms.2014.29.3.338_ref16 publication-title: J Urol doi: 10.1016/j.juro.2009.11.043 – volume: 63 start-page: 521 year: 2013 ident: 10.3346/jkms.2014.29.3.338_ref9 publication-title: Eur Urol doi: 10.1016/j.eururo.2012.06.003 – volume: 50 start-page: 665 year: 1997 ident: 10.3346/jkms.2014.29.3.338_ref21 publication-title: Urology doi: 10.1016/S0090-4295(97)00451-2 – volume: 173 start-page: 1930 year: 2005 ident: 10.3346/jkms.2014.29.3.338_ref20 publication-title: J Urol doi: 10.1097/01.ju.0000158039.94467.5d – volume: 360 start-page: 1320 year: 2009 ident: 10.3346/jkms.2014.29.3.338_ref6 publication-title: N Engl J Med doi: 10.1056/NEJMoa0810084 – volume: 17 start-page: 159 year: 1979 ident: 10.3346/jkms.2014.29.3.338_ref12 publication-title: Invest Urol – volume: 54 start-page: 709 year: 1999 ident: 10.3346/jkms.2014.29.3.338_ref19 publication-title: Urology doi: 10.1016/S0090-4295(99)00213-7 – volume: 61 start-page: 1110 year: 2012 ident: 10.3346/jkms.2014.29.3.338_ref15 publication-title: Eur Urol doi: 10.1016/j.eururo.2011.12.058 – volume: 16 start-page: 481 year: 2005 ident: 10.3346/jkms.2014.29.3.338_ref2 publication-title: Ann Oncol doi: 10.1093/annonc/mdi098 – volume: 18 start-page: 279 year: 2007 ident: 10.3346/jkms.2014.29.3.338_ref11 publication-title: Cancer Causes Control doi: 10.1007/s10552-006-0087-6 – volume: 360 start-page: 1310 year: 2009 ident: 10.3346/jkms.2014.29.3.338_ref4 publication-title: N Engl J Med doi: 10.1056/NEJMoa0810696 – volume: 186 start-page: 1830 year: 2011 ident: 10.3346/jkms.2014.29.3.338_ref14 publication-title: J Urol doi: 10.1016/j.juro.2011.06.057 – reference: 17206534 - Cancer Causes Control. 2007 Apr;18(3):279-85 – reference: 18462353 - Int J Urol. 2008 Jul;15(7):598-603 – reference: 10510933 - Urology. 1999 Oct;54(4):709-13 – reference: 15718248 - Ann Oncol. 2005 Mar;16(3):481-8 – reference: 21944136 - J Urol. 2011 Nov;186(5):1830-4 – reference: 22704727 - Eur Urol. 2013 Mar;63(3):521-7 – reference: 89106 - Invest Urol. 1979 Sep;17(2):159-63 – reference: 22244150 - Eur Urol. 2012 Jun;61(6):1110-4 – reference: 19297565 - N Engl J Med. 2009 Mar 26;360(13):1310-9 – reference: 21705045 - Urology. 2011 Aug;78(2):392-8 – reference: 15879784 - J Urol. 2005 Jun;173(6):1930-4 – reference: 9372872 - Urology. 1997 Nov;50(5):665-72 – reference: 9730460 - Urology. 1998 Sep;52(3):455-61 – reference: 12639653 - Urology. 2003 Mar;61(3):589-95 – reference: 20884114 - Eur Urol. 2010 Dec;58(6):851-64 – reference: 1707140 - N Engl J Med. 1991 Apr 25;324(17):1156-61 – reference: 19297566 - N Engl J Med. 2009 Mar 26;360(13):1320-8 – reference: 2441790 - Br J Urol. 1987 Jul;60(1):69-73 – reference: 20089283 - J Urol. 2010 Mar;183(3):963-8 – reference: 15163773 - N Engl J Med. 2004 May 27;350(22):2239-46 |
SSID | ssj0025523 |
Score | 2.069654 |
Snippet | Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy is still necessary to confirm prostate cancer (PCA). However, it is... Although prostate-specific antigen (PSA) is a very useful screening tool, prostate biopsy isstill necessary to confirm prostate cancer (PCA). However, it is... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 338 |
SubjectTerms | Adult Age Factors Aged Aged, 80 and over Area Under Curve Humans Male Middle Aged Multivariate Analysis Nomograms Original Predictive Value of Tests Prostate - physiology Prostate-Specific Antigen - blood Prostatic Neoplasms - diagnosis Prostatic Neoplasms - pathology Risk Factors ROC Curve 의학일반 |
Title | Nomogram for Prediction of Prostate Cancer with Serum Prostate Specific Antigen Less than 10 ng/mL |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24616581 https://www.proquest.com/docview/1506789266 https://pubmed.ncbi.nlm.nih.gov/PMC3945127 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001858339 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Korean Medical Science, 2014, 29(3), 186, pp.338-342 |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1598-6357 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: KQ8 dateStart: 19860101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1598-6357 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1598-6357 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: DIK dateStart: 19860101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1598-6357 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 1598-6357 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: 5-W dateStart: 19860101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1598-6357 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: RPM dateStart: 19860101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1598-6357 dateEnd: 20250831 omitProxy: true ssIdentifier: ssj0025523 issn: 1011-8934 databaseCode: M48 dateStart: 19860901 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwED9tQ0K8IL4pH5WREC8opc6X4weEEGLagO2JSnuzXMceU9uky1oJ_nvul6SFooF4aho7tXp3jn_nO_-O6KUDLVEpQ-Qw3XiFUJH2PouyqVI4sTJOQ8v2eZofTdJPZ9nZHm3SbXsBXl3r2qGe1KSZj75f_njHE_4tPM4EEcrZAsTbMh3FepTwveLV8jJCYSkEYPsqG_t0gxerGIZ_km4DDQyo2wpwvKgXEajZunM1f_nZnbVrv2rCdbD0z-zK35arwzt0u8eZ4n1nGHdpz1f36OZJH0m_T9PTetFmZglGrWLZoAE6EnXgb3V7zkg4mEQjsFcr2FTXi19NOKGJLCPBmgGhp5jzK1NgH17IsajO3yy-PKDJ4cevH46ivt5C5Bg0rSIZQuxCmXvp80znrFs_1p79Rb5WSOOwoVCh1FolUxl7m9s0z3VifVE6G8uQPKSDqq78YxIg6UlLaRkvWRDW2CQNTjEalTHP-lwPSG4kaVxPRo6aGHPDTgmkbyB9A-mbWJuE7xUDer19ZtlRcfyz9wtWkJm5CwMGbXye12bWGPYTjk3GLzYVc5-N-gzPKoRKbOXr9ZUB76IqNKOXAT3q1LkdEwx8jNvkgNSOorcdMN5uS3XxrWXuTnTKAEs9-Y9xn9It_J8u3e0ZHayatX_O-Gc1HTLyP_48bHcPhq01_wSEDAUo |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nomogram+for+prediction+of+prostate+cancer+with+serum+prostate+specific+antigen+less+than+10+ng%2FmL&rft.jtitle=Journal+of+Korean+medical+science&rft.au=Ahn%2C+Jae+Hyun&rft.au=Lee%2C+Jeong+Zoo&rft.au=Chung%2C+Moon+Kee&rft.au=Ha%2C+Hong+Koo&rft.date=2014-03-01&rft.issn=1598-6357&rft.eissn=1598-6357&rft.volume=29&rft.issue=3&rft.spage=338&rft_id=info:doi/10.3346%2Fjkms.2014.29.3.338&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-8934&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-8934&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-8934&client=summon |